RT Journal Article
SR Electronic
T1 What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device
JF Global Health: Science and Practice
JO GLOB HEALTH SCI PRACT
FD Johns Hopkins University- Global Health. Bloomberg School of Public Health, Center for Communication Programs
SP e2100789
DO 10.9745/GHSP-D-21-00789
VO 10
IS 5
A1 Kate H. Rademacher
A1 Tabitha Sripipatana
A1 Kendal Danna
A1 Deborah Sitrin
A1 Aurélie Brunie
A1 Katie M. Williams
A1 Kayode Afolabi
A1 Francia Rasoanirina
A1 Saumya Ramarao
A1 Anne Pfitzer
A1 Devon Cain
A1 Morgan Simon
A1 Elaine Menotti
A1 Anna Hazelwood
A1 Anthony Adindu Nwala
A1 Zainab Saidu
A1 Raveena Chowdhury
A1 Anne Taiwo
A1 Agnes Chidanyika
A1 Gathari Ndirangu
A1 Markus J. Steiner
A1 Marie Chantale Lepine
A1 Rick Homan
A1 Abdulmumin Saad
A1 John Vivalo
A1 Laneta J. Dorflinger
YR 2022
UL http://www.ghspjournal.org/content/10/5/e2100789.abstract
AB Key FindingsIn this review of early experiences providing the hormonal intrauterine device (IUD) in sub-Saharan Africa, we found: Continuation and satisfaction were high among hormonal IUD users in pilot settings and generally comparable to those of other long-acting reversible contraceptives.Hormonal IUD users reported positive attributes of the method including its effectiveness, long duration, convenience, potential for reduced bleeding, and fewer side effects compared to other hormonal methods.Coordination across diverse organizations, including alignment on a shared learning agenda and access strategy, ultimately contributed to expanded access to the method.Key ImplicationsAs several countries in sub-Saharan Africa are preparing to introduce the hormonal IUD on a wider scale, the addition of the hormonal IUD to the catalogs of the United States Agency for International Development and the United Nations Population Fund will help expand public-sector access.Additional investments in method introduction—including provider training, demand creation, robust implementation research, and monitoring and evaluation—will be critical to understanding how best to scale the method.In 2015, a global learning agenda for the hormonal intrauterine device (IUD) was developed with priority research questions regarding use of the method in low- and middle-income countries. In addition, members of the Hormonal IUD Access Group aligned on a strategy to expand access in the context of volunteerism and contraceptive method choice. This article synthesizes evidence generated since then and describes steps taken to address demand- and supply-side barriers to access. Findings demonstrated high continuation rates and satisfaction among hormonal IUD users that are comparable to other long-acting reversible contraceptives (LARCs). Across studies, a sizable number of users reported they would have chosen a short-acting method or no method at all if the hormonal IUD were not an option, which suggests that women did not see the hormonal IUD as interchangeable with other LARC options and thus it may fill an important niche in the market. With several countries now poised to scale up the method, resource mobilization will be key. On the demand side, investments in implementation research will be critical to understanding how best to launch and scale the method, while ensuring the sustainability of multiple quality-assured suppliers with affordable public-sector pricing will be necessary on the supply side.